Brief: Akebia Therapeutics Signs Commercial Supply Contract With Leading Dialysis Organization To Enable Access To Vafseo(Vadadustat)
22/10/2024 13:48
Oct 22 (Reuters) - Akebia Therapeutics Inc AKBA.O :
* AKEBIA THERAPEUTICS SIGNS COMMERCIAL SUPPLY CONTRACT WITH
LEADING DIALYSIS ORGANIZATION TO ENABLE ACCESS TO VAFSEO®
(VADADUSTAT) FOR PATIENTS ON DIALYSIS
* AKEBIA THERAPEUTICS INC - VAFSEO EXPECTED TO BE AVAILABLE
IN
U.S. IN JANUARY 2025
Source text for Eikon: ID:nPn2vRrQca
Further company coverage: AKBA.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Akebia Therapeutics
See all newsAkebia Q1 revenue falls, net income misses analyst estimates on higher expenses
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers To Its Board Of Directors
Akebia posts wider-than-expected Q4 net loss as higher expenses hurt
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule